Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 17, 2021 Filed Feb 19, 2021 23:00 UTC |
Stepan Richard FinnV.P. and Gen'l. Mgr., Polymers
|
GrantStock Appreciation Right · Derivative | 5,549 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006866 · form4.xml · derivative · entry 9 Stepan Richard Finn · CIK 0001839533 · V.P. and Gen'l. Mgr., Polymers 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,549 Underlying: Common Stock · 5,549 shares Expires 2031-02-16 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 23:00 UTC |
Stepan Richard FinnV.P. and Gen'l. Mgr., Polymers
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 1,850 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006866 · form4.xml · derivative · entry 8 Stepan Richard Finn · CIK 0001839533 · V.P. and Gen'l. Mgr., Polymers 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,850 Underlying: Stock Option (Right to Buy) · 1,850 shares Expires 2031-02-16 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 23:00 UTC |
Stepan Richard FinnV.P. and Gen'l. Mgr., Polymers
|
GrantCommon Stock | 55.207 | $123.65 | $6,826.35 |
DisclosureSEC source: 0001127602-21-006866 · form4.xml · nonDerivative · entry 7 Stepan Richard Finn · CIK 0001839533 · V.P. and Gen'l. Mgr., Polymers 10b5-1 filing: Not disclosed Ownership: Indirect · By ESOP II Trust Disclosed balance after: 916.056 Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 23:00 UTC |
Stepan Richard FinnV.P. and Gen'l. Mgr., Polymers
|
Exercise / conversionCommon Stock | 381 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006866 · form4.xml · nonDerivative · entry 6 Stepan Richard Finn · CIK 0001839533 · V.P. and Gen'l. Mgr., Polymers 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2020. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:52 UTC |
Moriarty Sean ThomasVP & GM Surfactants
|
Exercise / conversionPerformance Shares · Derivative | 1,918 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006864 · form4.xml · derivative · entry 6 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,918 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2020. F4 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020. F4 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:52 UTC |
Moriarty Sean ThomasVP & GM Surfactants
|
GrantPerformance Shares · Derivative | 1,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006864 · form4.xml · derivative · entry 5 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,940 Underlying: Common Stock · 1,940 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F3 · price: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:52 UTC |
Moriarty Sean ThomasVP & GM Surfactants
|
GrantStock Appreciation Right · Derivative | 7,400 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006864 · form4.xml · derivative · entry 4 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,400 Underlying: Common Stock · 7,400 shares Expires 2031-02-16 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:52 UTC |
Moriarty Sean ThomasVP & GM Surfactants
|
GrantStock Option (Right to Buy) · Derivative | 2,467 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006864 · form4.xml · derivative · entry 3 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,467 Underlying: Common Stock · 2,467 shares Expires 2031-02-16 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:52 UTC |
Moriarty Sean ThomasVP & GM Surfactants
|
GrantCommon Stock | 73.968 | $123.65 | $9,146.14 |
DisclosureSEC source: 0001127602-21-006864 · form4.xml · nonDerivative · entry 2 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: Not disclosed Ownership: Indirect · By ESOP II Trust Disclosed balance after: 3,982.453 Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:52 UTC |
Moriarty Sean ThomasVP & GM Surfactants
|
Exercise / conversionCommon Stock | 1,668 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006864 · form4.xml · nonDerivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,211.6445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2020. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:46 UTC |
Mergner Arthur WExec VP, Supply Chain
|
Exercise / conversionPerformance Shares · Derivative | 2,740 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006862 · form4.xml · derivative · entry 6 Mergner Arthur W · CIK 0001603410 · Exec VP, Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,740 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2020. F4 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020. F4 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:46 UTC |
Mergner Arthur WExec VP, Supply Chain
|
GrantPerformance Shares · Derivative | 2,182 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006862 · form4.xml · derivative · entry 5 Mergner Arthur W · CIK 0001603410 · Exec VP, Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,182 Underlying: Common Stock · 2,182 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F3 · price: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:46 UTC |
Mergner Arthur WExec VP, Supply Chain
|
GrantStock Appreciation Right · Derivative | 8,324 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006862 · form4.xml · derivative · entry 4 Mergner Arthur W · CIK 0001603410 · Exec VP, Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,324 Underlying: Common Stock · 8,324 shares Expires 2031-02-16 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:46 UTC |
Mergner Arthur WExec VP, Supply Chain
|
GrantStock Option (Right to Buy) · Derivative | 2,775 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006862 · form4.xml · derivative · entry 3 Mergner Arthur W · CIK 0001603410 · Exec VP, Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,775 Underlying: Common Stock · 2,775 shares Expires 2031-02-16 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:46 UTC |
Mergner Arthur WExec VP, Supply Chain
|
GrantCommon Stock | 73.968 | $123.65 | $9,146.14 |
DisclosureSEC source: 0001127602-21-006862 · form4.xml · nonDerivative · entry 2 Mergner Arthur W · CIK 0001603410 · Exec VP, Supply Chain 10b5-1 filing: Not disclosed Ownership: Indirect · By Esop II Trust Disclosed balance after: 3,449.151 Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:46 UTC |
Mergner Arthur WExec VP, Supply Chain
|
Exercise / conversionCommon Stock | 2,383 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006862 · form4.xml · nonDerivative · entry 1 Mergner Arthur W · CIK 0001603410 · Exec VP, Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,912.693 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2020. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:25 UTC |
Kabbes DavidVP GC & Secretary
|
GrantPerformance Shares · Derivative | 1,616 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006848 · form4.xml · derivative · entry 4 Kabbes David · CIK 0001632859 · VP GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,616 Underlying: Common Stock · 1,616 shares Expires not disclosed F2 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F2 · price: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F2 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F2 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:25 UTC |
Kabbes DavidVP GC & Secretary
|
GrantStock Appreciation Right · Derivative | 6,166 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006848 · form4.xml · derivative · entry 3 Kabbes David · CIK 0001632859 · VP GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,166 Underlying: Common Stock · 6,166 shares Expires 2031-02-16 F1 · derivative.exercise_date: Vests ratably over three years beginning on date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:25 UTC |
Kabbes DavidVP GC & Secretary
|
GrantStock Option (Right to Buy) · Derivative | 2,055 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006848 · form4.xml · derivative · entry 2 Kabbes David · CIK 0001632859 · VP GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,055 Underlying: Common Stock · 2,055 shares Expires 2031-02-16 F1 · derivative.exercise_date: Vests ratably over three years beginning on date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:25 UTC |
Kabbes DavidVP GC & Secretary
|
GrantCommon Stock | 73.968 | $123.65 | $9,146.14 |
DisclosureSEC source: 0001127602-21-006848 · form4.xml · nonDerivative · entry 1 Kabbes David · CIK 0001632859 · VP GC & Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · By ESOP II Trust Disclosed balance after: 127.089 Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:36 UTC |
Rojo LuisVP & Chief Financial Officer
|
Exercise / conversionPerformance Shares · Derivative | 2,822 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006858 · form4.xml · derivative · entry 6 Rojo Luis · CIK 0001738439 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,822 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2020. F4 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020. F4 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:36 UTC |
Rojo LuisVP & Chief Financial Officer
|
GrantPerformance Shares · Derivative | 2,182 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006858 · form4.xml · derivative · entry 5 Rojo Luis · CIK 0001738439 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,182 Underlying: Common Stock · 2,182 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F3 · price: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:36 UTC |
Rojo LuisVP & Chief Financial Officer
|
GrantStock Appreciation Right · Derivative | 8,324 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006858 · form4.xml · derivative · entry 4 Rojo Luis · CIK 0001738439 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,324 Underlying: Common Stock · 8,324 shares Expires 2031-02-16 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:36 UTC |
Rojo LuisVP & Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 2,775 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006858 · form4.xml · derivative · entry 3 Rojo Luis · CIK 0001738439 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,775 Underlying: Common Stock · 2,775 shares Expires 2031-02-16 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:36 UTC |
Rojo LuisVP & Chief Financial Officer
|
GrantCommon Stock | 73.968 | $123.65 | $9,146.14 |
DisclosureSEC source: 0001127602-21-006858 · form4.xml · nonDerivative · entry 2 Rojo Luis · CIK 0001738439 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Esop II Trust Disclosed balance after: 230.882 Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:36 UTC |
Rojo LuisVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 2,454 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006858 · form4.xml · nonDerivative · entry 1 Rojo Luis · CIK 0001738439 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,354 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2020. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:30 UTC |
Keiper Jason ScottVP & Chief Tech & Sust Officer
|
GrantPerformance Shares · Derivative | 970 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006852 · form4.xml · derivative · entry 4 Keiper Jason Scott · CIK 0001780101 · VP & Chief Tech & Sust Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 970 Underlying: Common Stock · 970 shares Expires not disclosed F2 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F2 · price: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F2 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F2 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:30 UTC |
Keiper Jason ScottVP & Chief Tech & Sust Officer
|
GrantStock Appreciation Right · Derivative | 3,700 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006852 · form4.xml · derivative · entry 3 Keiper Jason Scott · CIK 0001780101 · VP & Chief Tech & Sust Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,700 Underlying: Common Stock · 3,700 shares Expires 2031-02-16 F1 · derivative.exercise_date: Vests ratably over three years beginning on date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:30 UTC |
Keiper Jason ScottVP & Chief Tech & Sust Officer
|
GrantStock Option (Right to Buy) · Derivative | 1,233 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006852 · form4.xml · derivative · entry 2 Keiper Jason Scott · CIK 0001780101 · VP & Chief Tech & Sust Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,233 Underlying: Common Stock · 1,233 shares Expires 2031-02-16 F1 · derivative.exercise_date: Vests ratably over three years beginning on date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:30 UTC |
Keiper Jason ScottVP & Chief Tech & Sust Officer
|
GrantCommon Stock | 73.968 | $123.65 | $9,146.14 |
DisclosureSEC source: 0001127602-21-006852 · form4.xml · nonDerivative · entry 1 Keiper Jason Scott · CIK 0001780101 · VP & Chief Tech & Sust Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By ESOP II Trust Disclosed balance after: 121.747 Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:00 UTC |
Behrens Scott R.VP/GM Surfactants
|
Exercise / conversionPerformance Shares · Derivative | 2,740 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006816 · form4.xml · derivative · entry 6 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,740 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2020. F4 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020. F4 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:00 UTC |
Behrens Scott R.VP/GM Surfactants
|
GrantPerformance Shares · Derivative | 3,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006816 · form4.xml · derivative · entry 5 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,233 Underlying: Common Stock · 3,233 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:00 UTC |
Behrens Scott R.VP/GM Surfactants
|
GrantStock Appreciation Right · Derivative | 12,332 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006816 · form4.xml · derivative · entry 4 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,332 Underlying: Common Stock · 12,332 shares Expires 2031-02-16 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:00 UTC |
Behrens Scott R.VP/GM Surfactants
|
GrantStock Option (Right to Buy) · Derivative | 4,111 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006816 · form4.xml · derivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,111 Underlying: Common Stock · 4,111 shares Expires 2031-02-16 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:00 UTC |
Behrens Scott R.VP/GM Surfactants
|
GrantCommon Stock | 73.968 | $123.65 | $9,146.14 |
DisclosureSEC source: 0001127602-21-006816 · form4.xml · nonDerivative · entry 2 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Indirect · By Esop II Trust Disclosed balance after: 3,826.882 Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:00 UTC |
Behrens Scott R.VP/GM Surfactants
|
Exercise / conversionCommon Stock | 2,383 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006816 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,609.888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2020. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:14 UTC |
Catlett Janet AnneVP, CHRO
|
Exercise / conversionPerformance Shares · Derivative | 515 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006840 · form4.xml · derivative · entry 7 Catlett Janet Anne · CIK 0001747846 · VP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 515 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2020. F6 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020. F6 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:14 UTC |
Catlett Janet AnneVP, CHRO
|
GrantShare Units · Derivative | 1,228.053 | $123.73 | $151,947.00 |
DisclosureSEC source: 0001127602-21-006840 · form4.xml · derivative · entry 6 Catlett Janet Anne · CIK 0001747846 · VP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,588.251 Underlying: Common Stock · 1,228.053 shares Expires not disclosed F4 · derivative.exercise_price: Share Units convert on a one-for-one basis into Common Stock. F5 · derivative.exercise_date: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. F5 · derivative.expiration_date: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:14 UTC |
Catlett Janet AnneVP, CHRO
|
GrantPerformance Shares · Derivative | 970 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006840 · form4.xml · derivative · entry 5 Catlett Janet Anne · CIK 0001747846 · VP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 970 Underlying: Common Stock · 970 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F3 · price: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company common stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2023. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:14 UTC |
Catlett Janet AnneVP, CHRO
|
GrantStock Appreciation Right · Derivative | 3,700 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006840 · form4.xml · derivative · entry 4 Catlett Janet Anne · CIK 0001747846 · VP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,700 Underlying: Common Stock · 3,700 shares Expires 2031-02-16 F2 · derivative.exercise_date: Vests ratably over three years beginning on date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:14 UTC |
Catlett Janet AnneVP, CHRO
|
GrantStock Option (Right to Buy) · Derivative | 1,233 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006840 · form4.xml · derivative · entry 3 Catlett Janet Anne · CIK 0001747846 · VP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,233 Underlying: Common Stock · 1,233 shares Expires 2031-02-16 F2 · derivative.exercise_date: Vests ratably over three years beginning on date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:14 UTC |
Catlett Janet AnneVP, CHRO
|
GrantCommon Stock | 73.968 | $123.65 | $9,146.14 |
DisclosureSEC source: 0001127602-21-006840 · form4.xml · nonDerivative · entry 2 Catlett Janet Anne · CIK 0001747846 · VP, CHRO 10b5-1 filing: Not disclosed Ownership: Indirect · By Esop II Trust Disclosed balance after: 191.816 Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:14 UTC |
Catlett Janet AnneVP, CHRO
|
Exercise / conversionCommon Stock | 448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006840 · form4.xml · nonDerivative · entry 1 Catlett Janet Anne · CIK 0001747846 · VP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,142.593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2020. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 21:16 UTC |
Dearth Randall S.Director
|
GrantStock Units · Derivative | 4 | $119.32 | $477.28 |
DisclosureSEC source: 0001127602-21-000501 · form4.xml · derivative · entry 1 Dearth Randall S. · CIK 0001418244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,261 Underlying: Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of issuer Common Stock. F2 · derivative.exercise_date: Phantom stock units are payable in shares pursuant to the director's election either following separation from service or after a specified age. F2 · derivative.expiration_date: Phantom stock units are payable in shares pursuant to the director's election either following separation from service or after a specified age. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 21:13 UTC |
WEHMER EDWARD JDirector
|
GrantStock Awards · Derivative | 33 | $119.32 | $3,937.56 |
DisclosureSEC source: 0001127602-21-000492 · form4.xml · derivative · entry 1 WEHMER EDWARD J · CIK 0001244290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,784 Underlying: Common Stock · 33 shares Expires not disclosed F1 · derivative.exercise_price: Each Stock Award represents the right to receive one share of issuer common stock. F2 · derivative.exercise_date: Stock Awards are payable in shares pursuant to the director's election either following separation from service or after a specified age. F2 · derivative.expiration_date: Stock Awards are payable in shares pursuant to the director's election either following separation from service or after a specified age. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 21:11 UTC |
LAWTON GREGORY EDirector
|
GrantStock Awards · Derivative | 15 | $119.32 | $1,789.80 |
DisclosureSEC source: 0001127602-21-000484 · form4.xml · derivative · entry 1 LAWTON GREGORY E · CIK 0001180942 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,730 Underlying: Common Stock · 15 shares Expires not disclosed F1 · derivative.exercise_price: Each Stock Award represents the right to receive one share of issuer Common Stock. F2 · derivative.exercise_date: Stock Awards are payable in shares pursuant to the director's election either following separation from service or after a specified age. F2 · derivative.expiration_date: Stock Awards are payable in shares pursuant to the director's election either following separation from service or after a specified age. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 21:09 UTC |
Boyce Michael RossDirector
|
GrantStock Awards · Derivative | 1 | $119.32 | $119.32 |
DisclosureSEC source: 0001127602-21-000480 · form4.xml · derivative · entry 1 Boyce Michael Ross · CIK 0001335907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 751 Underlying: Common Stock · 1 shares Expires not disclosed F1 · derivative.exercise_price: Each Stock Award represents the right to receive one share of issuer common stock. F2 · derivative.exercise_date: Stock Awards are payable in shares pursuant to the director's election either following separation from service or after a specified age. F2 · derivative.expiration_date: Stock Awards are payable in shares pursuant to the director's election either following separation from service or after a specified age. Read SEC document |
| January 04, 2021 Filed Feb 19, 2021 23:24 UTC |
STEPAN F QUINN JRDirector · Chairman & CEO
|
GiftCommon Stock | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006871 · form4.xml · nonDerivative · entry 1 STEPAN F QUINN JR · CIK 0001229289 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 25,240 Read SEC document |
| January 04, 2021 Filed Feb 19, 2021 23:00 UTC |
Stepan Richard FinnV.P. and Gen'l. Mgr., Polymers
|
GiftCommon Stock | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006866 · form4.xml · nonDerivative · entry 5 Stepan Richard Finn · CIK 0001839533 · V.P. and Gen'l. Mgr., Polymers 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 22,647 Read SEC document |
| January 04, 2021 Filed Feb 19, 2021 23:00 UTC |
Stepan Richard FinnV.P. and Gen'l. Mgr., Polymers
|
GiftCommon Stock | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006866 · form4.xml · nonDerivative · entry 4 Stepan Richard Finn · CIK 0001839533 · V.P. and Gen'l. Mgr., Polymers 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughter Disclosed balance after: 22,647 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.